{"id":7488,"name":"Panakes Partners","slug":"panakes-partners","website":"panakes.it","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Vivasure Medical Ltd.","companyUrl":null,"stage":"Growth-stage round (post-Series B)","sector":"Medical devices / cardiovascular","investmentYear":null,"description":"Develops minimally invasive vascular closure technologies, notably PerQSeal, for large-bore vessel closure after cardiovascular procedures.","amountUsd":null,"relevanceNote":null,"fundName":"First MedTech fund (Panakes Fund launched in 2016)"},{"companyName":"Salvia BioElectronics","companyUrl":null,"stage":"Series A (lead investor) and Series B (follow-on as existing investor)","sector":"Neuromodulation / medical devices","investmentYear":null,"description":"Develops bioelectronic neuromodulation implants to treat chronic migraine and other neurological disorders.","amountUsd":null,"relevanceNote":null,"fundName":"First Panakes Fund (MedTech)"},{"companyName":"InnovHeart","companyUrl":null,"stage":"Series B round (led by Panakes Partners)","sector":"Structural heart / cardiovascular medical devices","investmentYear":null,"description":"Develops transcatheter mitral valve replacement (TMVR) systems for minimally invasive treatment of mitral valve disease.","amountUsd":null,"relevanceNote":null,"fundName":"First MedTech fund (Panakes Fund)"},{"companyName":"MMI (Medical Microinstruments)","companyUrl":null,"stage":"Large growth/Series B+ type €73M financing round","sector":"Robotic surgery / medical devices","investmentYear":null,"description":"Develops robotic microsurgery platforms enabling high-precision minimally invasive procedures.","amountUsd":null,"relevanceNote":null,"fundName":"First MedTech fund (Panakes Fund launched in 2016)"},{"companyName":"BetaGlue Technologies","companyUrl":null,"stage":"€10M financing round (growth, Series A–B range)","sector":"Oncology / radiotherapy medical devices","investmentYear":null,"description":"Develops an advanced radiotherapy platform for localized treatment of solid tumors using beta-emitting radionuclides with a biocompatible glue.","amountUsd":null,"relevanceNote":null,"fundName":"First MedTech fund (Panakes Fund)"},{"companyName":"Approxima","companyUrl":null,"stage":"Seed round (€1.6M) and Series A round (€7.3M)","sector":"Cardiovascular medical devices / structural heart","investmentYear":null,"description":"Develops a percutaneous right-ventricular reshaping technology to treat tricuspid valve regurgitation via minimally invasive repair.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Relief Srl","companyUrl":null,"stage":"Early-stage investment round (seed–Series A type, not explicitly labeled)","sector":"Urology / medical devices","investmentYear":null,"description":"Develops UroRelief, a miniaturized endo-urethral device for minimally invasive treatment of stress urinary incontinence (SUI).","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NanoPhoria Bioscience","companyUrl":null,"stage":"Series A (€83.5M)","sector":"Biotech / cardiovascular therapeutics","investmentYear":null,"description":"Develops a nano-in-micro pulmonary delivery platform and first-in-class peptide therapy (NP-MP1) targeting cardiac L-type calcium channels for heart failure and other chronic diseases.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":8,"partners":[{"id":25494,"name":"Fabrizio Landi","title":"General Partner","seniority":null,"focusTags":["MedTech","Diagnostics","Life Sciences","Life Science Investing"],"linkedinUrl":"https://www.linkedin.com/in/fabrizio-landi-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25497,"name":"Barbara Castellano","title":"Partner","seniority":null,"focusTags":["Cardiovascular Devices","Medical Devices / MedTech","Clinical Affairs & Regulatory Strategy"],"linkedinUrl":"https://www.linkedin.com/in/barbara-castellano-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25498,"name":"Rob Woodman","title":"Partner","seniority":null,"focusTags":["Biotechnology","Therapeutics","Early / Growth Life Sciences Companies"],"linkedinUrl":"https://www.linkedin.com/in/rob-woodman-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25495,"name":"Alessio Beverina","title":"General Partner","seniority":null,"focusTags":["Early-stage Startups","MedTech","Life Sciences","Technology Development & Venture Investing"],"linkedinUrl":"https://www.linkedin.com/in/alessio-beverina-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25496,"name":"Diana Saraceni","title":"General Partner","seniority":null,"focusTags":["Life Sciences Investments","Venture Capital","MedTech & Biotech"],"linkedinUrl":"https://www.linkedin.com/in/diana-saraceni-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25499,"name":"Marco Sardina","title":"Partner","seniority":null,"focusTags":["Drug Discovery & Development","Clinical R&D (Phase I-IV)","Medical Affairs"],"linkedinUrl":"https://www.linkedin.com/in/marco-sardina-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25500,"name":"Alessio Piuma","title":"Principal","seniority":null,"focusTags":["Deal Sourcing","Early-Stage Investment Analysis","Medical Technologies"],"linkedinUrl":"https://www.linkedin.com/in/alessio-piuma-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":25501,"name":"Andrea Ballerini","title":"Investment Manager","seniority":null,"focusTags":["Scientific Evaluation","Preclinical Assets","Early Stage Biotech / MedTech"],"linkedinUrl":"https://www.linkedin.com/in/andrea-ballerini-/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}